DNA Script
Founded Year
2014Stage
Series C - II | AliveTotal Raised
$335.04MLast Raised
$35M | 2 yrs agoAbout DNA Script
DNA Script is a biotech start-up that manufactures de novo synthetic nucleic acids using an enzymatic technology. The company aims to introduce a biochemical process for DNA and RNA synthesis based on the use of efficient enzymes. This technology mimics the way nature produces genetic code and enables enhanced performance while minimizing the use of harsh chemicals.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Research containing DNA Script
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned DNA Script in 1 CB Insights research brief, most recently on Oct 5, 2021.
Expert Collections containing DNA Script
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
DNA Script is included in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
238 items
Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.
DNA Script Patents
DNA Script has filed 34 patents.
The 3 most popular patent topics include:
- Molecular biology
- DNA
- Genetics
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/14/2020 | 6/27/2023 | Molecular biology, DNA, Genetics, Biotechnology, RNA | Grant |
Application Date | 10/14/2020 |
|---|---|
Grant Date | 6/27/2023 |
Title | |
Related Topics | Molecular biology, DNA, Genetics, Biotechnology, RNA |
Status | Grant |
Latest DNA Script News
May 22, 2023
PARIS & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Bioeconomy--DNA Script announced the broad commercial availability of the fully automated SYNTAX™ DNA printing platform
DNA Script Frequently Asked Questions (FAQ)
When was DNA Script founded?
DNA Script was founded in 2014.
Where is DNA Script's headquarters?
DNA Script's headquarters is located at 67 avenue de Fontainebleau, Le Kremlin-Bicetre.
What is DNA Script's latest funding round?
DNA Script's latest funding round is Series C - II.
How much did DNA Script raise?
DNA Script raised a total of $335.04M.
Who are the investors of DNA Script?
Investors of DNA Script include HealthCor Management, Sino Biopharmaceutical, Baillie Gifford & Co., T. Rowe Price, Irving Investors and 26 more.
Who are DNA Script's competitors?
Competitors of DNA Script include Catalog Technologies.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare DNA Script to Competitors
Evonetix develops a desktop, short-latency solution to synthesize DNA to facilitate the field of synthetic biology, with applications across industries including healthcare, pharma, biotech, food and agriculture, and data storage. It leverages semiconductor-controlled synthesis on silicon which enables ultra-parallel DNA preparation, and moving capacity from remote service centers. The company was founded in 2015 and is based in Cambridge, U.K.
Molecular Assemblies develops an enzymatic DNA synthesis technology designed to power DNA-based products. Enzymatic DNA synthesis can write long, pure DNA, which is required to free the potential of synthetic biology applications, such as personalized medicines (including CAR-T cell therapies and CRISPR gene editing) and advanced agricultural and industrial products, through gene development and DNA-based data storage.
Helixworks Technologies operates as a biotechnology company. It specializes in deoxyribonucleic acid (DNA) synthesis. The company was founded in 2013 and is based in Cork, Ireland.
Iridia is a deoxyribonucleic acid (DNA) data storage platform. It stores medical records, financial information, and other sensitive data in a secure way. It was founded in 2016 and is based in Carlsbad, California.
Developer of instrumentation for gene synthesis analysis. The company develops a DNA and RNA synthesizer for molecular biology research purposes. The platform aims to deliver less expensive, higher quality, reduced turn-around-time oligonucleotide synthesis solutions.
Catalog develops technology to store digital information in deoxyribonucleic acid (DNA) molecules. It provides a platform for digital deoxyribonucleic acid (DNA) data storage and computation. It was founded in 2016 and is based in Boston, Massachusetts.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
